Okay, let's tackle this question step by step. The question is asking for an example of a gain of function mutation. First, I need to recall what a gain of function mutation is. From what I remember, gain of function mutations are those where the mutant protein has a new or enhanced function compared to the normal protein. This is different from loss of function, where the protein's function is reduced or lost.

So, the options aren't provided, but I need to think of common examples. Let me brainstorm some. For instance, in cancer, certain mutations can activate oncogenes. The BCR-ABL fusion gene in chronic myeloid leukemia (CML) is a classic example. The fusion protein has constitutive tyrosine kinase activity, which leads to uncontrolled cell proliferation. That's a gain of function because the protein is now active all the time, which it wouldn't be normally.

Another example could be the G12V mutation in KRAS. Normally, KRAS cycles between active and inactive states, but the mutation locks it in the active state, continuously signaling for cell growth. That's another gain of function. Also, some ion channel mutations can cause hyperactivity, like in certain types of epilepsy or arrhythmias. For example, the sodium channel Nav1.5 mutations causing long QT syndrome might be gain of function if they increase the channel's activity.

Wait, but I need to make sure these are indeed gain of function. Sometimes, mutations can be dominant negative, which is different. For example, a dominant negative mutation would interfere with the normal function of the protein. So, it's important to distinguish between gain of function, loss of function, and dominant negative.

Now, considering possible options that might be presented: if one of the options is BCR-ABL fusion, that's correct. If another option is a loss of function mutation like in cystic fibrosis (CFTR deletion), that's incorrect. Similarly, a dominant negative mutation like in some tumor suppressors (p53) would also be incorrect. The question is looking for the example where the mutation gives the protein a new or enhanced function.

So, the correct answer would be the one that refers to a fusion gene or a point mutation leading to constitutive activation. The other options are either loss of function or different types of mutations. I need to ensure that the explanation clearly differentiates between these types and explains why each incorrect option is wrong.

**Core Concept**
Gain-of-function mutations confer a *new or enhanced activity* to a protein, often leading to pathologic effects. These are distinct from loss-of-function (reduced activity) or dominant-negative (interferes with normal protein function) mutations. Classic examples include oncogenic fusion proteins and constitutively active receptors.

**Why the Correct Answer is Right**
The BCR-ABL fusion protein in chronic myeloid leukemia (CML) is a textbook gain-of-function mutation. The Philadelphia chromosome results from a reciprocal translocation between chromosomes 9 and 22, fusing the *ABL* tyrosine kinase domain to the *BCR* gene. This creates a constitutively active tyrosine kinase that drives uncontrolled cell proliferation. The mutant protein bypasses normal regulatory mechanisms, leading to clonal expansion of myeloid blasts.

**Why Each Wrong Option is Incorrect**
**Option A:** A loss-of-function mutation

✓ Correct Answer: D. Huntington's disease